Peptide Academy · Metabolic

SLU-PP-332

Also known as ERR agonist exercise mimetic

Educational research summary, not medical advice. Many compounds here are not approved for human use. Talk to a licensed clinician before making any health decision.

The Peptide Academy is free to read. Members also get the research protocols for SLU-PP-332, dose and vial tracking, and an AI Advisor with cited sources. Try it all free for 7 days, no card needed.

Start my free 7-day trial

What is SLU-PP-332?

A non-peptide estrogen-related-receptor agonist studied as an 'exercise in a pill' compound.

How it works

Activates ERRα/β/γ in skeletal muscle, inducing the oxidative-fiber gene program normally triggered by endurance exercise.

Published research

  • Mouse studies show increased endurance, fat oxidation and metabolic improvements; no human trials

Half-life

~Hours (experimental ERR agonist; limited PK data)

Cautions

Preclinical compound; no human safety data.

Side effects & fixes

Common side effects

  • —Human side-effect data is limited or absent for this compound
  • —Injection-site redness, itching or soreness is the most commonly reported effect for injected research peptides

Histamine reactions

Possible at the injection site, as with most injected peptides.

Common fixes

  • Rotate injection sites (abdomen, thighs, upper arms) and stay at least an inch from the last spot.
  • Let the alcohol swab dry fully, let the solution reach room temperature, and inject slowly with a fresh needle.
  • A cold compress for 5–10 minutes eases a red or itchy welt; it should fade within a day.
  • For mild itching, redness or flushing, a non-drowsy over-the-counter antihistamine (such as cetirizine or loratadine) is commonly used — check with a pharmacist first, especially if you take other medicines.
  • Start low, change one thing at a time, and keep a log of how you feel.

Stop and get help

  • Any unexpected or severe symptom — stop and contact a doctor.
  • Stop and get emergency help for swelling of the face, lips, tongue or throat, trouble breathing, widespread hives, chest pain or fainting.

Basis: Limited data; general experience with injected peptides. Educational only, not medical advice.

Medication concerns

Theoretical: no human interaction studies
  • Diabetes medicines

    These metabolic research compounds act on energy and glucose pathways and may lower blood sugar further.

  • Cholesterol and liver-processed medicines

    Not studied together; liver and lipid labs are worth tracking.

  • Everything else you take, including supplements

    Bring a full list of medicines and supplements to your pharmacist or clinician before starting.

Basis: No human interaction studies; concerns follow from AMPK, PPAR or Rev-ERB metabolic mechanisms. Educational only, not medical advice. Never stop or change a prescribed medicine without your prescriber.

Protocols & tracking are members-only

Members see the research protocols for SLU-PP-332, plan schedules, track every dose and vial, and ask the AI Advisor questions with cited sources. Try every Researcher feature free for 7 days, no card needed.

More metabolic compounds